Predictive Value of Seizure Frequency at Onset for Long-Term Seizure Control
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Epilepsy is a chronic neurological disorder characterized by recurrent unprovoked seizures, and achieving long-term seizure control remains a major therapeutic goal. Early clinical features at diagnosis, particularly seizure frequency at onset and early response to antiseizure drugs (AEDs), may provide important prognostic information. Previous studies suggest that higher early seizure burden and poor initial response to AEDs are associated with unfavorable long-term outcomes; however, the predictive value of seizure frequency and number at onset remains insufficiently explored in contemporary cohorts. This retrospective cohort study will be conducted at the Neurology Clinic of Assiut University Children's Hospital between February 2026 and January 2027. It will include patients with tractable and intractable newly diagnosed epilepsy. Data will be collected from clinical records and structured interviews, covering demographic characteristics, detailed seizure history (with emphasis on seizure frequency at onset), treatment details, early and long-term seizure control, adherence, and adverse effects. Neurological examination findings, EEG results, and neuroimaging data will be reviewed to support epilepsy classification and identify potential prognostic factors. The primary outcome is to assess whether higher seizure frequency at onset is associated with poorer long-term seizure control. Statistical analysis will include descriptive statistics, comparative analyses between seizure-frequency groups, multivariate logistic regression to identify independent predictors, and ROC curve analysis to evaluate predictive accuracy. Ethical approval, informed consent, and data confidentiality will be ensured throughout the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2026
CompletedStudy Start
First participant enrolled
January 10, 2026
CompletedFirst Posted
Study publicly available on registry
January 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 30, 2027
January 15, 2026
January 1, 2026
1 year
January 7, 2026
January 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
To assess whether higher seizure frequency at onset is associated with poorer long-term seizure control.
12 months
Interventions
No intervention was applied. This is an observational study in which participants underwent routine clinical and radiological assessments only, with no experimental or therapeutic intervention.
Eligibility Criteria
All patients with tractable and intractable epilepsy.
You may qualify if:
- \- All patients with tractable and intractable epilepsy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postgraduate Researcher, Faculty of Medicine, Assiut University
Study Record Dates
First Submitted
January 7, 2026
First Posted
January 15, 2026
Study Start
January 10, 2026
Primary Completion (Estimated)
January 10, 2027
Study Completion (Estimated)
January 30, 2027
Last Updated
January 15, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share